Baring Private Equity Partners is bullish on Indian markets and says that India's value accretion potential remains good. After two years, the monsoon is looking good which can spur demand and consumption, said Rahul Bhasin, Managing Partner at Baring Private Equity Partners. Indian pharma companies contribute 6 percent to global pharma sales and Indian pharma companies will gain significant market share in the next 20 years. He said that global debt has gone up since 2008 and that ensures that money stays easy and opportunities for business to grow will be very good.
0 comments:
Post a Comment